The present invention provides methods for diagnosing a patient with emphysema or COPD by detecting the levels of EMAP Il in a sample. Alternatively, methods are provided for determining the susceptibility of a patient to develop emphysema or COPD by detecting the levels of EMAP Il in a sample. The levels of EMAP Il may be determined by immunoassay techniques. The present invention also provides methods for treating patients with emphysema or COPD by administering a therapeutically effective amount of an EMAP Il neutralizing compound. The compound may be an antibody, siRNA, antisense RNA or an antagonist of CXCR3.
申请公布号
WO2009117680(A3)
申请公布日期
2010.01.21
申请号
WO2009US37842
申请日期
2009.03.20
申请人
INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION;CLAUSS, MATTHIAS;PETRACHE, IRINA;VOSWINCKEL, ROBERT
发明人
CLAUSS, MATTHIAS;PETRACHE, IRINA;VOSWINCKEL, ROBERT